Darkhan Kanayev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Darkhan Kanayev has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Kanatbek Mukantayev
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan
6 shared publications - Kanat Tursunov
National Center for Biotechnology
5 shared publications - Laura Tokhtarova
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan
5 shared publications - Bisultan Abirbekov
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan
4 shared publications - Malika Nurtleu
National Center for Biotechnology
2 shared publications - Zhansaya Adish
Laboratory of Immunochemistry and Immunobiotechnology, National Center for Biotechnology, 010000, Astana, Kazakhstan
2 shared publications
Latest Publications
- Open Access
- 11 July 2025
- Published by Veterinary World in Veterinary World
- Vol. 18 (7) , 1881-1890
Development and validation of a recombinant Rap1-based lateral flow immunoassay for rapid serodiagnosis of bovine babesiosis in Kazakhstan
Background and Aim: Bovine babesiosis, caused by Babesia bovis, poses significant economic challenges to Kazakhstan’s cattle industry. Early and accurate detection is crucial for interrupting transmission cycles, particularly in regions lacking advanced diagnostic infrastructure. This study aimed to develop a rapid lateral flow immunoassay (LFIA) using a recombinant C-terminal fragment of the recombinant rhoptry-associated protein 1 (rRap1) antigen for the serodiagnosis of bovine babesiosis. Materials and Methods: A C-terminal fragment (amino acids 345–480) of the B. bovis Rap1 gene was codon optimized and expressed in Escherichia coli. The recombinant protein was purified using metal-affinity chromatography and validated through sodium dodecyl sulfate polyacrylamide gel electrophoresis, Western blotting, and nanoflow liquid chromatography-tandem mass spectrometry. A diagnostic evaluation was performed using enzyme-linked immunosorbent assay (ELISA) and LFIA on sera from 102 uninfected and 15 infected cattle, all of which had been pre-tested using polymerase chain reaction. Colloidal gold-protein G conjugates were prepared for LFIA, and test conditions were optimized for antigen concentration and serum dilution. Assay performance was compared with previously published LFIAs. Results: A 21-kDa rRap1 protein was successfully expressed and demonstrated high specificity to positive control sera. ELISA and LFIA both detected antibodies in 13 of 15 infected samples (sensitivity 86.6%). Specificity was 90.1% for ELISA and 88.2% for LFIA. Receiver operating characteristic analysis showed an area under the curve of 0.83, and Cohen’s Kappa indicated fair-to-moderate agreement between ELISA and LFIA. The LFIA exhibited comparable performance to assays based on merozoite surface antigen 1 or spherical body protein antigens, marking the first successful use of a B. bovis Rap1 C-terminal fragment for LFIA-based field diagnostics in Kazakhstan. Conclusion: The developed rRap1-based LFIA is a promising, field-deployable diagnostic tool for bovine babesiosis, offering rapid results without the need for laboratory equipment. Despite slightly lower sensitivity than ELISA, its simplicity, cost-effectiveness, and specificity support its use in large-scale epidemiological surveillance. Further validation in diverse field conditions and cattle populations is recommended to refine sensitivity and broaden applicability. Keywords: Babesia bovis, bovine babesiosis, enzyme-linked immunosorbent assay, lateral flow immunoassay, rapid diagnostics, recombinant rhoptry-associated protein 1, serodiagnosis.
- 11 July 2025
- Published by Veterinary World in Veterinary World
- Vol. 18 (7) , 1881-1890
Open AccessDevelopment and validation of a recombinant Rap1-based lateral flow immunoassay for rapid serodiagnosis of bovine babesiosis in Kazakhstan
Background and Aim: Bovine babesiosis, caused by Babesia bovis, poses significant economic challenges to Kazakhstan’s cattle industry. Early and accurate detection is crucial for interrupting transmission cycles, particularly in regions lacking advanced diagnostic infrastructure. This study aimed to develop a rapid lateral flow immunoassay (LFIA) using a recombinant C-terminal fragment of the recombinant rhoptry-associated protein 1 (rRap1) antigen for the serodiagnosis of bovine babesiosis. Materials and Methods: A C-terminal fragment (amino acids 345–480) of the B. bovis Rap1 gene was codon optimized and expressed in Escherichia coli. The recombinant protein was purified using metal-affinity chromatography and validated through sodium dodecyl sulfate polyacrylamide gel electrophoresis, Western blotting, and nanoflow liquid chromatography-tandem mass spectrometry. A diagnostic evaluation was performed using enzyme-linked immunosorbent assay (ELISA) and LFIA on sera from 102 uninfected and 15 infected cattle, all of which had been pre-tested using polymerase chain reaction. Colloidal gold-protein G conjugates were prepared for LFIA, and test conditions were optimized for antigen concentration and serum dilution. Assay performance was compared with previously published LFIAs. Results: A 21-kDa rRap1 protein was successfully expressed and demonstrated high specificity to positive control sera. ELISA and LFIA both detected antibodies in 13 of 15 infected samples (sensitivity 86.6%). Specificity was 90.1% for ELISA and 88.2% for LFIA. Receiver operating characteristic analysis showed an area under the curve of 0.83, and Cohen’s Kappa indicated fair-to-moderate agreement between ELISA and LFIA. The LFIA exhibited comparable performance to assays based on merozoite surface antigen 1 or spherical body protein antigens, marking the first successful use of a B. bovis Rap1 C-terminal fragment for LFIA-based field diagnostics in Kazakhstan. Conclusion: The developed rRap1-based LFIA is a promising, field-deployable diagnostic tool for bovine babesiosis, offering rapid results without the need for laboratory equipment. Despite slightly lower sensitivity than ELISA, its simplicity, cost-effectiveness, and specificity support its use in large-scale epidemiological surveillance. Further validation in diverse field conditions and cattle populations is recommended to refine sensitivity and broaden applicability. Keywords: Babesia bovis, bovine babesiosis, enzyme-linked immunosorbent assay, lateral flow immunoassay, rapid diagnostics, recombinant rhoptry-associated protein 1, serodiagnosis.
- Open Access
- 20 March 2025
- Published by S.Seifullin Kazakh Agro Technical University in HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY: Veterinary sciences
- No. 5(009),p. 15-27
The effect of interleukin-15 on bovine natural killer and CD8+ T cells and its potential in treating viral infections
Interleukin-15 (IL-15) is a promising cytokine for immunotherapy of human cancers and bovine viral infections. IL-15 indirectly has a negative effect on tumor and virus-infected cells by activating the signaling pathways of proliferation and activation of natural killer (NK) and memory CD8+ T cells. IL-15 therapy may have widespread clinical use, particularly when combined with chimeric antigen receptor (CAR) T or CAR NK cells. Additionally, the use of IL-15 in combination with checkpoint inhibitors and other therapies holds promise as a treatment for cancer and viral infections. Understanding the biological characteristics of IL-15 is crucial for developing effective therapeutic strategies. This study aimed to explore recent advances in IL-15 research, focusing on its antitumor mechanisms within the tumor microenvironment, advances in IL-15-based therapies for bovine viral infections, and its integration with other treatment approaches, including monoclonal antibodies.
- 20 March 2025
- Published by S.Seifullin Kazakh Agro Technical University in HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY: Veterinary sciences
- No. 5(009),p. 15-27
Open AccessThe effect of interleukin-15 on bovine natural killer and CD8+ T cells and its potential in treating viral infections
Interleukin-15 (IL-15) is a promising cytokine for immunotherapy of human cancers and bovine viral infections. IL-15 indirectly has a negative effect on tumor and virus-infected cells by activating the signaling pathways of proliferation and activation of natural killer (NK) and memory CD8+ T cells. IL-15 therapy may have widespread clinical use, particularly when combined with chimeric antigen receptor (CAR) T or CAR NK cells. Additionally, the use of IL-15 in combination with checkpoint inhibitors and other therapies holds promise as a treatment for cancer and viral infections. Understanding the biological characteristics of IL-15 is crucial for developing effective therapeutic strategies. This study aimed to explore recent advances in IL-15 research, focusing on its antitumor mechanisms within the tumor microenvironment, advances in IL-15-based therapies for bovine viral infections, and its integration with other treatment approaches, including monoclonal antibodies.
- Open Access
- 15 September 2024
- Published by Veterinary World in Veterinary World
- Vol. 17 (9) , 2096-2103
Cytotoxic T-lymphocyte antigen 4 and programmed cell death ligand 1 blockade increases the effectiveness of interleukin-15 immunotherapy in a bovine leukemia model
Background and Aim: Bovine interleukin 15 (bIL15) is a potential immunotherapy that can block the spread of bovine leukemia virus (BLV). However, immune checkpoints that maintain body homeostasis may reduce their effectiveness. Thus, an analysis of the effectiveness of bIL15 while blocking negative immune regulators is necessary. We aimed to obtain recombinant bIL15 (rbIL15) and determine its percentage using monoclonal antibodies against bovine cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death ligand 1 (PD-L1). To achieve this goal, peripheral blood mononuclear cells (PBMCs) from healthy and BLV+ cattle were treated with bIL15 using a CTLA-4– and PD-L1–blocking algorithm. Materials and Methods: The codon-optimized bIL15 gene was synthesized under de novo conditions using polymerase chain reaction (PCR). The synthesized gene was cloned into pET28 and transformed into electrocompetent Escherichia coli BL21 cells; rbIL15 was purified using metal affinity chromatography and analyzed using sodium dodecyl-sulfate– polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting. The expression of the Bcl2, STAT3, and STAT5 genes was studied using qualitative PCR. An enzyme-linked immunosorbent assay (ELISA) was used to analyze interferon (IFN)-γ production by rbIL15-treated mononuclear cells. Results: Analysis of rbIL15 using SDS-PAGE and western blotting revealed a specific product weighing 24 kDa. The optimal conditions for rbIL15 induction were 0.2 mM isopropyl-β-D-1-galactopyranoside and 37°C. When rbIL15 was added to PBMCs from healthy cattle, the Bcl2, STAT3, and STAT5 genes were expressed. ELISA of the culture medium of rbIL15-treated PBMCs revealed IFN-γ production. When PBMCs from healthy cows were treated with rbIL15, CTLA-4, and PD-L1 blockade together, they did not produce more IFN-γ than the rbIL15 group. Using PBMCs from BLV+ cattle, combination treatment increased IFN-γ production. Conclusion: The biological activity of rbIL15 is characterized by the induction of transcription factors and the production of IFN-γ. Using rbIL15 with CTLA-4 and PD-L1 blockade in PBMCs from healthy and BLV+ cows led to the production of a transcription factor and cytokine. The results demonstrate the possibility of using this method to improve immunity and immunological memory in patients with chronic viral infections. Keywords: bovine interleukin-15, bovine leukemia virus, cytotoxic T-lymphocyte antigen 4, monoclonal antibody, programmed cell death ligand 1.
- 15 September 2024
- Published by Veterinary World in Veterinary World
- Vol. 17 (9) , 2096-2103
Open AccessCytotoxic T-lymphocyte antigen 4 and programmed cell death ligand 1 blockade increases the effectiveness of interleukin-15 immunotherapy in a bovine leukemia model
Background and Aim: Bovine interleukin 15 (bIL15) is a potential immunotherapy that can block the spread of bovine leukemia virus (BLV). However, immune checkpoints that maintain body homeostasis may reduce their effectiveness. Thus, an analysis of the effectiveness of bIL15 while blocking negative immune regulators is necessary. We aimed to obtain recombinant bIL15 (rbIL15) and determine its percentage using monoclonal antibodies against bovine cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death ligand 1 (PD-L1). To achieve this goal, peripheral blood mononuclear cells (PBMCs) from healthy and BLV+ cattle were treated with bIL15 using a CTLA-4– and PD-L1–blocking algorithm. Materials and Methods: The codon-optimized bIL15 gene was synthesized under de novo conditions using polymerase chain reaction (PCR). The synthesized gene was cloned into pET28 and transformed into electrocompetent Escherichia coli BL21 cells; rbIL15 was purified using metal affinity chromatography and analyzed using sodium dodecyl-sulfate– polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting. The expression of the Bcl2, STAT3, and STAT5 genes was studied using qualitative PCR. An enzyme-linked immunosorbent assay (ELISA) was used to analyze interferon (IFN)-γ production by rbIL15-treated mononuclear cells. Results: Analysis of rbIL15 using SDS-PAGE and western blotting revealed a specific product weighing 24 kDa. The optimal conditions for rbIL15 induction were 0.2 mM isopropyl-β-D-1-galactopyranoside and 37°C. When rbIL15 was added to PBMCs from healthy cattle, the Bcl2, STAT3, and STAT5 genes were expressed. ELISA of the culture medium of rbIL15-treated PBMCs revealed IFN-γ production. When PBMCs from healthy cows were treated with rbIL15, CTLA-4, and PD-L1 blockade together, they did not produce more IFN-γ than the rbIL15 group. Using PBMCs from BLV+ cattle, combination treatment increased IFN-γ production. Conclusion: The biological activity of rbIL15 is characterized by the induction of transcription factors and the production of IFN-γ. Using rbIL15 with CTLA-4 and PD-L1 blockade in PBMCs from healthy and BLV+ cows led to the production of a transcription factor and cytokine. The results demonstrate the possibility of using this method to improve immunity and immunological memory in patients with chronic viral infections. Keywords: bovine interleukin-15, bovine leukemia virus, cytotoxic T-lymphocyte antigen 4, monoclonal antibody, programmed cell death ligand 1.
- Open Access
- 25 June 2024
- Published by National Center for Biotechnology in Eurasian Journal of Applied Biotechnology
- No. 2,p. 16-23
MONOCLONAL ANTIBODIES AGAINST THE BABESIA BOVIS RAP1 ANTIGEN: OBTAINING AND CHARACTERIZATION
Bovine babesiosis is a disease caused by parasites of the genus Babesia. One of the main Babesia genera causing disease in cattle, according to the International Office of Epizootics (OIE), is Babesia bovis. Recovered cattle become permanent latent carriers and can be a source of tick infestation and spread of infection. Despite susceptibility and specificity, diagnostic methods such as enzyme-linked immunosorbent assays (ELISA) and indirect fluorescent antibody assays (IFA) have some disadvantages. These methods require a long analysis time, the use of specialized equipment and trained specialists. At the same time, immunochromatographic tests (ICA) are widely used in veterinary practice today. ICA is characterized by a short analysis time, ease of performance and interpretation of results. The main components of the ICA test system are monoclonal antibodies. As a result of the studies, three mAbs against the recombinant Rap1 antigen of B. bovis were obtained. The resulting mAbs have high diagnostic characteristics. A conjugate of colloidal gold with mAbs is capable of detecting the Rap1 antigen of the causative agent of babesiosis in cattle.
- 25 June 2024
- Published by National Center for Biotechnology in Eurasian Journal of Applied Biotechnology
- No. 2,p. 16-23
Open AccessMONOCLONAL ANTIBODIES AGAINST THE BABESIA BOVIS RAP1 ANTIGEN: OBTAINING AND CHARACTERIZATION
Bovine babesiosis is a disease caused by parasites of the genus Babesia. One of the main Babesia genera causing disease in cattle, according to the International Office of Epizootics (OIE), is Babesia bovis. Recovered cattle become permanent latent carriers and can be a source of tick infestation and spread of infection. Despite susceptibility and specificity, diagnostic methods such as enzyme-linked immunosorbent assays (ELISA) and indirect fluorescent antibody assays (IFA) have some disadvantages. These methods require a long analysis time, the use of specialized equipment and trained specialists. At the same time, immunochromatographic tests (ICA) are widely used in veterinary practice today. ICA is characterized by a short analysis time, ease of performance and interpretation of results. The main components of the ICA test system are monoclonal antibodies. As a result of the studies, three mAbs against the recombinant Rap1 antigen of B. bovis were obtained. The resulting mAbs have high diagnostic characteristics. A conjugate of colloidal gold with mAbs is capable of detecting the Rap1 antigen of the causative agent of babesiosis in cattle.
- Open Access
- 11 October 2022
- Published by Veterinary World in Veterinary World
- Vol. 15 (10) , 2384-2390
Effect of thioredoxin on the immunogenicity of the recombinant P32 protein of lumpy skin disease virus
Background and Aim: The rapid spread of lumpy skin disease (LSD) globally poses a serious threat to the agricultural sector. The timely and accurate diagnosis of the disease is crucial to control LSD. This study aimed to determine the effect of thioredoxin on the immunogenicity of the recombinant P32 (rP32) protein of LSD virus (LSDV). Since the P32 protein is poorly soluble, it is often expressed by adding an auxiliary sequence of a highly soluble partner protein such as thioredoxin. Materials and Methods: The P32 gene fragment was amplified using a polymerase chain reaction from genomic DNA used as a template. The resulting DNA fragments were cloned into the pET32a vector, and transformed into Escherichia coli BL21 (DE3) cells through electroporation. Purification of the rP32 protein was performed using a HisTrap column. Purified rP32 protein fused with thioredoxin (rP32Trx) was characterized by western blotting, liquid chromatography with tandem mass spectrometry and indirect enzyme-linked immunosorbent assay (ELISA). Results: Indirect ELISA revealed that, despite the lower molecular weight, the main part of the antibodies in the serum of immunized mice was directed against thioredoxin and not the target P32 protein. Thus, the antibody titers against rP32Trx were 1:102400, whereas antibody titers against heterologous recombinant 3BTrx and PD1Trx proteins were 1:25600 and 1:51200, respectively. Concurrently, the antibodies did not bind to the heterologous recombinant PD1 protein, which did not contain thioredoxin. Conclusion: The results showed that the rP32 protein fused with the partner protein thioredoxin could not be used to obtain polyclonal and monoclonal antibodies. However, the recombinant fusion protein rP32Trx can be used to develop a serological test to detect antibodies, since antibodies against thioredoxin were not detected in the animal sera.
- 11 October 2022
- Published by Veterinary World in Veterinary World
- Vol. 15 (10) , 2384-2390
Open AccessEffect of thioredoxin on the immunogenicity of the recombinant P32 protein of lumpy skin disease virus
Background and Aim: The rapid spread of lumpy skin disease (LSD) globally poses a serious threat to the agricultural sector. The timely and accurate diagnosis of the disease is crucial to control LSD. This study aimed to determine the effect of thioredoxin on the immunogenicity of the recombinant P32 (rP32) protein of LSD virus (LSDV). Since the P32 protein is poorly soluble, it is often expressed by adding an auxiliary sequence of a highly soluble partner protein such as thioredoxin. Materials and Methods: The P32 gene fragment was amplified using a polymerase chain reaction from genomic DNA used as a template. The resulting DNA fragments were cloned into the pET32a vector, and transformed into Escherichia coli BL21 (DE3) cells through electroporation. Purification of the rP32 protein was performed using a HisTrap column. Purified rP32 protein fused with thioredoxin (rP32Trx) was characterized by western blotting, liquid chromatography with tandem mass spectrometry and indirect enzyme-linked immunosorbent assay (ELISA). Results: Indirect ELISA revealed that, despite the lower molecular weight, the main part of the antibodies in the serum of immunized mice was directed against thioredoxin and not the target P32 protein. Thus, the antibody titers against rP32Trx were 1:102400, whereas antibody titers against heterologous recombinant 3BTrx and PD1Trx proteins were 1:25600 and 1:51200, respectively. Concurrently, the antibodies did not bind to the heterologous recombinant PD1 protein, which did not contain thioredoxin. Conclusion: The results showed that the rP32 protein fused with the partner protein thioredoxin could not be used to obtain polyclonal and monoclonal antibodies. However, the recombinant fusion protein rP32Trx can be used to develop a serological test to detect antibodies, since antibodies against thioredoxin were not detected in the animal sera.
- Open Access
- 26 August 2022
- Published by Veterinary World in Veterinary World
- Vol. 15 (8) , 2067-2071
Optimization of polymerase chain reaction for the identification of Roe deer, Saiga, and Siberian stag living in Kazakhstan
Background and Aim: One of the reasons for the decline in the number of wild species of artiodactyls is poaching and the illegal trading of animal products. Molecular genetic identification of animals from a biological sample effectively proves poaching cases and illegal trade of animal products. This study aimed to develop a polymerase chain reaction (PCR) test that allows for species identification of artiodactyl animals that are most often subject to poaching. Materials and Methods: Genomic DNA was extracted from meat and blood samples of animals killed by poachers using commercial kits. Three pairs of primers were designed and used to amplify the cytochrome b gene fragment of Roe deer, Saiga antelope, and Siberian stag. Results: The proposed protocol allows amplification of specific PCR products of 542 bp with Roe deer DNA, 587 bp with Saiga DNA, and 525 bp with Siberian stag DNA. Specificity analysis showed no cross activity with DNA from other animal species. The detection limit of PCR ranged from 15.6 pg to 1.9 pg of DNA in 25 μL of the reaction mixture. Conclusion: Sequencing the amplified products and subsequent comparison with the corresponding reference sequence showed a similarity ranging from 99.99% to 100%. The PCR based on the developed primers demonstrated high sensitivity and specificity when using DNA from homogeneous and heterogeneous animals.
- 26 August 2022
- Published by Veterinary World in Veterinary World
- Vol. 15 (8) , 2067-2071
Open AccessOptimization of polymerase chain reaction for the identification of Roe deer, Saiga, and Siberian stag living in Kazakhstan
Background and Aim: One of the reasons for the decline in the number of wild species of artiodactyls is poaching and the illegal trading of animal products. Molecular genetic identification of animals from a biological sample effectively proves poaching cases and illegal trade of animal products. This study aimed to develop a polymerase chain reaction (PCR) test that allows for species identification of artiodactyl animals that are most often subject to poaching. Materials and Methods: Genomic DNA was extracted from meat and blood samples of animals killed by poachers using commercial kits. Three pairs of primers were designed and used to amplify the cytochrome b gene fragment of Roe deer, Saiga antelope, and Siberian stag. Results: The proposed protocol allows amplification of specific PCR products of 542 bp with Roe deer DNA, 587 bp with Saiga DNA, and 525 bp with Siberian stag DNA. Specificity analysis showed no cross activity with DNA from other animal species. The detection limit of PCR ranged from 15.6 pg to 1.9 pg of DNA in 25 μL of the reaction mixture. Conclusion: Sequencing the amplified products and subsequent comparison with the corresponding reference sequence showed a similarity ranging from 99.99% to 100%. The PCR based on the developed primers demonstrated high sensitivity and specificity when using DNA from homogeneous and heterogeneous animals.